Poly (ε-caprolactone) microparticles containing Levobunolol HCl prepared by a multiple emulsion (W/O/W) solvent evaporation technique: Effects of some formulation parameters on microparticle characteristics

References

• Alex R, Bodmeier R. Encapsulation of water-soluble drugs by a modified solvent evaporation method. I. Effect of process and formulation variables on drug entrapment. J Microencapsulation 1990; 7: 347–355
   PubMed Web of Science ®Google Scholar
• Allemann E, Gurny R, Doelker E. Drug loaded nanoparticles, preparation methods and drug targeting issues. Eur J Pharm Biopharm 1993; 39: 173–191
   Web of Science ®Google Scholar
• Antunes MCM, Felisberti MI. Blends of poly(hydroxybutyrate) and poly (ε-caprolactone) obtained from melting mixture. Polimeros 2005; 15: 134–138
   Google Scholar
• Bala I, Bhardwaj V, Hariharan S, Sitterberg J, Bakowsky U, Ravi Kumar MNV. Design of biodegradable nanoparticles: A novel approach to encapsulating poorly soluble phytochemical ellagic acid. Nanotechnology 2005; 16: 2819–2822
   Web of Science ®Google Scholar
• Benoit MA, Baras B, Gillard J. Preparation and characterization of protein-loaded poly (ε-caprolactone) microparticles for oral vaccine delivery. Int J Pharm 1999; 184: 73–84
   PubMed Web of Science ®Google Scholar
• Blanco MD, Alonso MJ. Development and characrerization of protein-loaded poly(lactide-coglycolide) nanopheres. Eur J Pharm Biopharm 1997; 43: 287–294
   Web of Science ®Google Scholar
• Bodmeier R, McGinity JW. Polylactic acid microspheres containing quinidine base and quinidine sulphate prepared by the solvent evaporation technique: II. Some process parameters influencing the preparation and properties of microcapsules. J Microencapsulation 1987a; 4: 289–297
   PubMed Web of Science ®Google Scholar
• Bodmeier R, McGinity JW. The preparation and evaluation of drug containing poly(D,L-Lactide) micropheres formed by the solvent evaporation method. Pharm Res 1987b; 4: 465–471
   PubMed Web of Science ®Google Scholar
• Bodmeier R, McGinity JW. Solvent selection in the preparation of poly (D,L-lactide) micropheres prepared by the solvent evaporation method. Int J Pharm 1988; 43: 179–186
   Web of Science ®Google Scholar
• Boury F, Ivanova T, Panaiotov I, Proust JE, Bois A, Richou J. Dynamic properties of poly(D,L-lactide) and polyvinyl alcohol monolayers at the air/water and dichloromethane/water interfaces. J Colloid Interface Sci 1995; 169: 380–392
   Web of Science ®Google Scholar
• Cinotti A, Cinotti D, Grant W, Jacobs I, Galin M, Silverstone D, Shin D, Esters J, Lee J, Bouchey R, et al. Levobunolol vs timolol for open angle glaucoma and ocular hypertension. Am J Oftalmol 1985; 99: 11–17
   Google Scholar
• Costa P, Lobo JMS. Modeling and comparison of dissolution profiles. Eur J Pharm Sci 2001; 13: 123–133
   PubMed Web of Science ®Google Scholar
• Couvreur P, Barratt G, Fattal E, Legrand P, Vauthier C. Nanocapsule technology: A review. Crit Rev Therapeut Drug Carrier Syst 2002; 19: 99–134
   PubMed Web of Science ®Google Scholar
• Desai SD, Blanchard J. Pluronic® F127-based ocular delivery system containing biodegradable polyisobutylcyanoacrylate nanocapsules of pilocarpine. Drug Deliv 2000; 7: 201–207
   PubMed Web of Science ®Google Scholar
• Dinarvand R, Mirfattahi S, Atyabi F. Preparation, characterization an in vitro drug release of isosorbide dinitrate micropheres. J Microencapsulation 2002; 19: 73–81
   PubMed Web of Science ®Google Scholar
• Ding S. Recent developments in ophthalmic drug delivery. Pharm Sci Tech Today 1998; 1: 328–335
   Google Scholar
• Elbahri Z, Taverdet JL. Optimization of an herbicide release from ethylcellulose micropheres. Polym Bull 2005; 54: 353–363
   Web of Science ®Google Scholar
• El-Kamel AH. In vitro and in vivo evaluation of Pluronic F127-based ocular delivery systems for timolol maleate. Int J Pharm 2002; 241: 47–55
   PubMed Web of Science ®Google Scholar
• Gonzalez JP, Clissold SP. Ocular levobunolol: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy. Drugs 1987; 34: 648–661
   PubMed Web of Science ®Google Scholar
• Govender S, Lutchman D, Pillay V, Chetty DJ, Govender T. Enhancing drug incorporation into tetracycline-loaded chitosan microspheres for periodontal therapy. J Microencapsulation 2006; 23: 750–761
   PubMed Web of Science ®Google Scholar
• Govender T, Stolnik S, Garnett MC, Illum L, Davis SS. PLGA nanoparticles prepared by nanoprecipitation: Drug loading and release studies of a water soluble drug. J Contr Rel 1999; 57: 171–185
   PubMed Web of Science ®Google Scholar
• Hoyng PFJ, Beek LMV. Pharmacological therapy for glaucoma: A review. Drugs 2000; 59: 411–434
   PubMed Web of Science ®Google Scholar
• Huatan H, Collett JH, Attwood D. The microencapsulation of protein using a novel ternary blend based on poly (ε-caprolactone). J Microencapsulation 1995; 12: 557–567
   PubMed Web of Science ®Google Scholar
• Guidline ICH. [Internet] 2005. Validation of analytical procedures: Text and methodology Q2(R1), Available online at: http:/www.ich.gov/LOB/media/MEDIA417.pdf
   Google Scholar
• Jeong JC, Lee J, Cho K. effects of crystalline microstructure on drug release behaviour of poly (ε-caprolactone) micropheres. J Contr Rel 2003; 92: 249–258
   PubMed Web of Science ®Google Scholar
• Jones DS, Pearce KJ. An investigation of the effects of some process variables on the microencapsulation of propranolol hydrochloride by the solvent evaporation method. Int J Pharm 1995; 118: 199–205
   Web of Science ®Google Scholar
• Le Bourlais C, Acar L, Zia H, Sado PA, Needham T, Leverge R. Ophtalmic drug delivery systems-recent advances. Prog Retinal Eye Res 1998; 17: 33–58
   PubMed Web of Science ®Google Scholar
• Lee SC, Oh JT, Jang MH, Chung SI. Quantitative analysis of polyvinyl alcohol on the surface of poly (D,L-lactide-co-glycolide) microparticles prepared by solvent evaporation method: Effect of particle size and PVA concentration. J Contr Rel 1999; 59: 123–132
   PubMed Web of Science ®Google Scholar
• Lionzo MIZ, Ré MI, Guterres SS, Pholmann AR. Microparticles prepared with poly(hydroxybutyrate-co-hydroxyvalerate) and poly (ε-caprolactone) blends to control the release of drug model. J Microencapsulation 2007; 24: 175–186
   PubMed Web of Science ®Google Scholar
• Luan X, Skupin M, Siepman J, Bodmeier R. Key parameters affecting the initial release (burst) and encapsulation efficiency of peptide-containing poly(lactide-co-glycolide) microparticles. Int J Pharm 2006; 324: 168–175
   PubMed Web of Science ®Google Scholar
• Mainardes RM, Evangelista RC. PLGA nanoparticles containing praziquantel: Effect of formulation variables on size distribution. Int J Pharm 2005; 290: 137–144
   PubMed Web of Science ®Google Scholar
• Marchal-Heussler L, Fessi H, Devissaguet JP, Hoffman M, Maincent P. Colloidal drug delivery systems for the eye a comparison of the efficacy of three different polymers: Polyisobutylcyanoacrylate, polylactic-co-glycolic acid, poly-epsilon-caprolacton. STP Pharma Sci 1992; 2: 98–104
   Google Scholar
• Meng FT, Ma GH, Liu YD, Qiu W, Su ZG. Microencapsulation of bovine haemoglobin with high bio-activity and high entrapment efficiency using a W/O/W double emulsion technique. Colloids Surf B Biointerfaces 2004; 33: 177–183
   Web of Science ®Google Scholar
• Miyazaki S, Hashiguchi N, Hou W-M, Yokouchi C, Takada M. Preparation and evaluation in vitro and in vivo of fibrinogen microspheres containing adriamycin. Chem Pharm Bull 1986; 34: 3384–3393
   PubMed Web of Science ®Google Scholar
• Niwa T, Takeuchi H, Hino T, Kunou N, Kawashima Y. Preparation of biodegradable nanopheres of water-soluble and insoluble drugs with D,L-lactide/glycolide copolymer by a novel spontaneous emulsification solvent diffusion method, and the drug release behaviour. J Contr Rel 1993; 25: 89–98
   Web of Science ®Google Scholar
• Parikh RH, Parikh JR, Dubey RR, Soni HN, Kapadia KN. Poly(D,L-lactide-co-glycolide) micropheres containing 5-fluorouracil: Optimization of process parameters. AAPS PharmSciTech [serial online]; 4(2), Article 13. 2003, Available online at: www.aapspharmscitech.org, accessed 18 June 2007
   Google Scholar
• Peltonen L, Aitta J, Hyvonen S, Karjalainen M, Hirvonen J. Improved entrapment efficiency of hydrophilic drug substance during nanoprecipitation of poly(l)lactide nanoparticles. AAPS. Pharm Sci Tech 5(1) 2004; 16: 1–6
   Google Scholar
• Pérez MH, Zinnuti C, Lamprecht A, Ubrich N, Astier A, Hoffman M, Bodmeier R, Maincent P. The preparation and the evaluation of poly (ε-caprolactone) microparticles containing both a lipophilic and hydrophilic drug. J Contr Rel 2000; 65: 429–438
   PubMed Web of Science ®Google Scholar
• Pignatello R, Bucolo C, Ferrra P, Maltese A, Puleo A, Puglisi G. Eudrogit RS100® nanosuspansion for the ophthalmic controlled delivery of ibuprofen. Eur J Pharm Sci 2002; 16: 53–61
   PubMed Web of Science ®Google Scholar
• Quintanar-Guerrero D, Fessi H, Alleman E, Doelker E. Influence of stabilizing agents and preparative variables on the formation of poly(D,L-lactic acid) nanoparticles by an emulsification-diffusion technique. Int J Pharm 1996; 143: 133–141
   Web of Science ®Google Scholar
• Rafati H, Coombes AGA, Adler J, Holland J, Davis SS. Protein loaded poly(Dl-lactide-co-gylcolide) microparticles for oral administration: Formulation, structural and release characteristics. J Contr Rel 1997; 43: 89–102
   Web of Science ®Google Scholar
• Schugens C, Laruelle N, Nihant N, Grandfils C, Jérome R, Teyssié P. Effects of the emulsion stability on the morphology and porosity of semicrystalline poly l-lactide microparticles prepared by W/O/W double emulsion-evaporation. J Contr Rel 1994; 32: 161–176
   Web of Science ®Google Scholar
• Shin IG, Kim SY, Lee YM, Cho CS, Sung KY. Methoxy poly (ethylene glycol) ε-caprolactone amphiphilic block copolymeric micelle containing indomethacin. I. preparation and characterization. J Contr Rel 1998; 51: 1–11
   PubMed Web of Science ®Google Scholar
• Singh M, Briones M, Ott G, O’Hagan D. Cationic microparticles: A potent delivery systems for DNA vaccines. Proc Natl Acad Sci USA 2000; 97: 811–816
   PubMed Web of Science ®Google Scholar
• Sintzel MB, Bernatchez SF, Tabatabay C, Gurny R. Biomaterials in ophthalmic drug delivery. Eur J Pharm Biopharm 1996; 42: 358–374
   Web of Science ®Google Scholar
• Song CX, Labhasetwar V, Murphy H, Qu X, Humphrey WR, Shebuski RJ, Levy RJ. Formulation and characterization of biodegradable nanoparticles for intravascular local drug delivery. J Contr Rel 1997; 43: 197–212
   Web of Science ®Google Scholar
• Ubrich N, Bouillot P, Pellerin C, Hoffman M, Maincent P. Preparation and characterization of propranolol hydrochloride nanoparticles: A comparative study. J Contr Rel 2004; 97: 291–300
   PubMed Web of Science ®Google Scholar
• Walters RT, Maloney S, Slater D, Liss C, Wilson H, Hartenbaum D. Efficacy and tolerability of 0.5% timolol maleate ophthalmic gel-forming solution QD compared with 0.5% levobunolol hydrochloride BID in patients with open-angle glaucoma or ocular hypertension. Clin Therapeut 1998; 20: 1170–1178
   PubMedGoogle Scholar
• Yang YY, Chung TS, Bai XL, Chan WK. Effects of preparation conditions on morphology and release profiles of biodegradable polymeric microspheres containing protein fabricated by double emulsion method. Chem Eng Sci 2000; 55: 2223–2236
   Web of Science ®Google Scholar
• Zambaux MF, Bonneaux F, Gref R, Maincent P, Dellacherie E, Alonso MJ, Labrude P, Vigneron C. Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion method. J Contr Rel 1998; 50: 31–40
   PubMed Web of Science ®Google Scholar
• Zidan AS, Sammour OA, Hammad MA, Megrab NA, Hussain MD, Khan MA, Habib MJ. Formulation of anastrozole microparticles as biodegradable anticancer drug carriers. AAPS PharmSciTech [serial online] 2006; 7(3), Article 61. Available online at http:/aapspharmscitech.org, accessed 2 July 2007
   Google Scholar
• Zimmer AK, Kreuter J. Micropheres and nanoparticles used in ocular delivery systems. Adv Drug Deliv Rev 1995; 16: 61–73
   Web of Science ®Google Scholar